Inmune Bio had a rough day and is now down -6.60%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.
The company isn't at an immediate support or resistance level that might be predictive. Inmune Bio hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. INMB might find some support at the 1.68 level, buyers might push the price back up from here. But it's not very clear what will happen.